Invasive Mould Infection clinical trials

Explore recruiting invasive mould infection clinical trials.

Recruiting invasive mould infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Invasive Mould Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Multicenter, Randomized, Double-blind Study of Safety and Efficacy of EL219 versus Standard of Care (Liposomal Amphotericin B followed by Voriconazole) for Early Antifungal Therapy of Suspected Invasive Mould Infections

Belgium, France, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Invasive Mould Infection trials by city

Invasive Mould Infection in Toronto Invasive Mould Infection in Vancouver Invasive Mould Infection in Montreal Invasive Mould Infection in Calgary Invasive Mould Infection in Edmonton Invasive Mould Infection in Ottawa Invasive Mould Infection in Winnipeg Invasive Mould Infection in Quebec City Invasive Mould Infection in Hamilton Invasive Mould Infection in Kitchener Invasive Mould Infection in London Invasive Mould Infection in Halifax Invasive Mould Infection in New York Invasive Mould Infection in Los Angeles Invasive Mould Infection in Chicago Invasive Mould Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease